Back to search results

Enriched Holistic Care to Reduce Maternal Morbidity

This study is testing a new approach called the Maternity Care Home Model (MCHM) to help reduce severe maternal morbidity (SMM), which refers to serious health problems during or after pregnancy. The MCHM combines regular prenatal care with social services like help with benefits, social work, doula support, and mental health resources, all in one place. We want to see if this integrated care can improve health outcomes for Black, Indigenous, Asian, or Latina (BIPOC) pregnant patients between 16 and 55 years old who plan to deliver at two specific Penn hospitals. Success would mean a reduction in SMM from delivery up to one year after birth. The current status of this study is unclear.

Study design
This is a randomized controlled trial with a planned enrollment of 2300 participants. Participants will be randomly assigned to either the Maternity Care Home Model or standard care.
What's involved
Participants will receive prenatal care and be followed from pregnancy through one year postpartum.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed from delivery up to one year postpartum to measure severe maternal morbidity.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06245057

Enriched Holistic Care to Eradicate Disparities in Maternal Morbidity

Recruiting
NAAges 16–55InterventionalSupportive care
University of Pennsylvania
~2,300 participants
Updated 2026-04-21 on ClinicalTrials.gov
What's tested:Maternity care home model (MCHM)

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Severe Maternal Morbidity (SMM)
Measured over Delivery to one year postpartum

Conditions

Morbidity;Perinatal

Explore related trials

Pregnancy

Where it's being run

2 sites across 1 states
Pennsylvania2

Study leadership

  • Sindhu K Srinivas, MD, MSCE · PRINCIPAL_INVESTIGATOR · University of Pennsylvania

Who to contact

Sindhu K Srinivas, MD, MSCE
[email protected]
215-662-2982
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Pregnant patients who self-identify as Black, Indigenous, Asian, or Latina (BIPOC)
Ages 16-55
Presentation to the hospital in pregnancy - this includes prenatal care or the emergency department
Plan to deliver at the 2 Penn hospital sites
Patients must be able to read and understand English or Spanish
Participants must be willing and able to sign the informed consent form

Exclusion

Unable to provide written consent by being unable to read or sign informed consent.
Enrolled in ENHANCED Trial in a prior pregnancy
Already participating in Maternity Care Home Model (MCHM)

What this trial measures

  • Severe Maternal Morbidity (SMM)Delivery to one year postpartum

    The CDC definition of SMM. We will also include postpartum hemorrhage, infection, thrombosis, readmission and maternal mortality within this definition